Endothelial Senescence Contributes to Heart Failure with Preserved Ejection Fraction in an Aging Mouse Model

Circulation: Heart Failure

Volumn 10, Issue 6, 2017, Pages

  Gevaert, Andreas B ^a,b   Shakeri, Hadis ^a   Leloup, Arthur J ^a   Van Hove, Cor E ^a   De Meyer, Guido R Y ^a   Vrints, Christiaan J ^a,b   Lemmens, Katrien ^a   Van Craenenbroeck, Emeline M ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

aging; endothelium; heart failure; heart failure with preserved ejection fraction; senescence

Indexed keywords

ACETYLCHOLINE; COLLAGEN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PROTEIN P53;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR INFLAMMATION; CELL FUNCTION; CELLULAR SENESCENCE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXERCISE; FEMALE; FIBROSING ALVEOLITIS; HEART ATRIUM ENLARGEMENT; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION; ANIMAL; CELL AGING; DISEASE MODEL; HEART FAILURE; HEART STROKE VOLUME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; CELL AGING; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEART FAILURE; MICE; STROKE VOLUME;

EID: 85021103931     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.003806     Document Type: Article

References (30)

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327. doi: 10. 1161/CIR. 0b013e31829e8776.
2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/ Task Force Members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-2200. doi: 10. 1093/eurheartj/ehw128.
3. Kitzman DW, Herrington DM, Brubaker PH, Moore JB, Eggebeen J, Haykowsky MJ. Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction. Hypertension. 2013;61:112-119. doi: 10. 1161/ HYPERTENSIONAHA. 111. 00163.
4. Franssen C, Chen S, Unger A, Korkmaz HI, De Keulenaer GW, Tschöpe C, Leite-Moreira AF, Musters R, Niessen HW, Linke WA, Paulus WJ, Hamdani N. Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail. 2016;4:312-324. doi: 10. 1016/j. jchf. 2015. 10. 007.
5. Adams V, Alves M, Fischer T, Rolim N, Werner S, Schütt N, Bowen TS, Linke A, Schuler G, Wisloff U. High-intensity interval training attenuates endothelial dysfunction in a Dahl salt-sensitive rat model of heart failure with preserved ejection fraction. J Appl Physiol (1985). 2015;119:745-752. doi: 10. 1152/japplphysiol. 01123. 2014.
6. Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2014;11:507-515. doi: 10. 1038/nrcardio. 2014. 83.
7. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263-271. doi: 10. 1016/j. jacc. 2013. 02. 092.
8. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729-740. doi: 10. 1038/nrm2233.
9. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol. 2013;10:274-283. doi: 10. 1038/nrcardio. 2013. 30.
10. Horgan S, Watson C, Glezeva N, Baugh AJ. Murine models of diastolic dysfunction and heart failure with preserved ejection fraction. J Card Fail. 2014;20:984-995. doi: 10. 1016/j. cardfail. 2014. 09. 001.
11. Reed AL, Tanaka A, Sorescu D, Liu H, Jeong E-M, Sturdy M, Walp ER, Dudley SC, Sutliff RL. Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse. Am J Physiol Hear Circ Physiol. 2011;301:H824-H831. doi: 10. 1152/ajpheart. 00407. 2010.
12. Novella S, Dantas AP, Segarra G, Vidal-Gómez X, Mompeón A, Garabito M, Hermenegildo C, Medina P. Aging-related endothelial dysfunction in the aorta from female senescence-accelerated mice is associated with decreased nitric oxide synthase expression. Exp Gerontol. 2013;48:1329-1337. doi: 10. 1016/j. exger. 2013. 08. 003.
13. Rizzo NO, Maloney E, Pham M, Luttrell I, Wessells H, Tateya S, Daum G, Handa P, Schwartz MW, Kim F. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler Thromb Vasc Biol. 2010;30:758-765. doi: 10. 1161/ATVBAHA. 109. 199893.
14. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501-H512. doi: 10. 1152/ajpheart. 00138. 2005
15. van Langen J, Fransen P, Van Hove CE, Schrijvers DM, Martinet W, De Meyer GR, Bult H. Selective loss of basal but not receptor-stimulated relaxation by endothelial nitric oxide synthase after isolation of the mouse aorta. Eur J Pharmacol. 2012;696:111-119. doi: 10. 1016/j. ejphar. 2012. 09. 016.
16. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209. doi: 10. 1161/01. RES. 73. 1. 205.
17. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension. 1996;28:269-275. doi: 10. 1161/01. HYP. 28. 2. 269.
18. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressureoverloaded rats. Circulation. 2002;106:130-135. doi: 10. 1161/01. CIR. 0000020689. 12472. E0.
19. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, Nadal-Ginard B, Frustaci A, Leri A, Maseri A, Anversa P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res. 2003;93:604-613. doi: 10. 1161/01. RES. 0000093985. 76901. AF.
20. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446:444-448. doi: 10. 1038/nature05602.
21. Gogiraju R, Xu X, Bochenek ML, Steinbrecher JH, Lehnart SE, Wenzel P, Kessel M, Zeisberg EM, Dobbelstein M, Schäfer K. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. J Am Heart Assoc. 2015;4:1-22. doi: 10. 1161/JAHA. 115. 001770.
22. Lim SL, Lam CS, Segers VF, Brutsaert DL, De Keulenaer GW. Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction. Eur Heart J. 2015;36:2050-2060. doi: 10. 1093/eurheartj/ehv132.
23. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschöpe C. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation. 2007;116:637-647. doi: 10. 1161/ CIRCULATIONAHA. 106. 661983.
24. Conceição G, Heinonen I, Lourenço AP, Duncker DJ, Falcão-Pires I. Animal models of heart failure with preserved ejection fraction. Neth Heart J. 2016;24:275-286. doi: 10. 1007/s12471-016-0815-9.
25. Hay I, Rich J, Ferber P, Burkhoff D, Maurer MS. Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol. 2005;288:H1203-H1208. doi: 10. 1152/ajpheart. 00681. 2004.
26. Chow B, Rabkin SW. The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev. 2015;20:291-303. doi: 10. 1007/s10741-015-9471-1.
27. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006;114:2138-2147. doi: 10. 1161/ CIRCULATIONAHA. 106. 632745.
28. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845-854. doi: 10. 1016/j. jacc. 2010. 03. 077.
29. Tartière-Kesri L, Tartière JM, Logeart D, Beauvais F, Cohen Solal A. Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2012;59:455-461. doi: 10. 1016/j. jacc. 2011. 10. 873.
30. Hemmeryckx B, Hoylaerts MF, Deloose E, Van Hove CE, Fransen P, Bult H, Lijnen HR. Age-associated pro-inflammatory adaptations of the mouse thoracic aorta. Thromb Haemost. 2013;110:785-794. doi: 10. 1160/TH13-01-0022.